[HTML][HTML] Liposome-polymer complex for drug delivery system and vaccine stabilization

AK Umar, N Wathoni, JH Zothantluanga, S Das… - Heliyon, 2022 - cell.com
Liposomes have been used extensively as micro-and nanocarriers for hydrophobic or
hydrophilic molecules. However, conventional liposomes are biodegradable and quickly …

Nanovaccine: A novel approach in immunization

SM Gheibi Hayat, M Darroudi - Journal of cellular physiology, 2019 - Wiley Online Library
Despite great advances in the field of vaccination, there are still needs for novel and
effective vaccines because still no effective vaccines have been produced for some …

Potential applications and human biosafety of nanomaterials used in nanomedicine

H Su, Y Wang, Y Gu, L Bowman… - Journal of Applied …, 2018 - Wiley Online Library
With the rapid development of nanotechnology, potential applications of nanomaterials in
medicine have been widely researched in recent years. Nanomaterials themselves can be …

Applications of nanomaterials as vaccine adjuvants

M Zhu, R Wang, G Nie - Human vaccines & immunotherapeutics, 2014 - Taylor & Francis
Vaccine adjuvants are applied to amplify the recipient's specific immune responses against
pathogen infection or malignancy. A new generation of adjuvants is being developed to …

The immunological and pharmacokinetic evaluation of Lipid-PLGA hybrid nanoparticle-based oxycodone vaccines

DL Walter, Y Bian, H Hu, FA Hamid, K Rostamizadeh… - Biomaterials, 2025 - Elsevier
The current opioid epidemic is one of the most profound public health crises facing the
United States. Despite that it has been under the spotlight for years, available treatments for …

Engineering the lipid layer of lipid–PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability

Y Hu, R Hoerle, M Ehrich, C Zhang - Acta biomaterialia, 2015 - Elsevier
Lipid–polymer hybrid nanoparticles (NPs), consisting of a polymeric core and a lipid shell,
have been intensively examined as delivery systems for cancer drugs, imaging agents, and …

Immunotherapies for the treatment of drug addiction

MK Hossain, M Davidson, E Kypreos, J Feehan… - Vaccines, 2022 - mdpi.com
Substance use disorders (SUD) are a serious public health concern globally. Existing
treatment platforms suffer from a lack of effectiveness. The development of immunotherapies …

Preclinical efficacy and characterization of candidate vaccines for treatment of opioid use disorders using clinically viable carrier proteins

F Baruffaldi, AH Kelcher, M Laudenbach… - Molecular …, 2018 - ACS Publications
Vaccines may offer a new treatment strategy for opioid use disorders and opioid-related
overdoses. To speed translation, this study evaluates opioid conjugate vaccines containing …

Biologics to treat substance use disorders: Current status and new directions

M Pravetoni - Human vaccines & immunotherapeutics, 2016 - Taylor & Francis
Biologics (vaccines, monoclonal antibodies (mAb), and genetically modified enzymes) offer
a promising class of therapeutics to treat substance use disorders (SUD) involving abuse of …

A nanoparticle-based nicotine vaccine and the influence of particle size on its immunogenicity and efficacy

Z Zhao, Y Hu, R Hoerle, M Devine, M Raleigh… - … , Biology and Medicine, 2017 - Elsevier
Traditional hapten-protein conjugate nicotine vaccines have shown less than desired
immunological efficacy due to their poor recognition and internalization by immune cells. We …